GB1473318A - Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof - Google Patents

Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof

Info

Publication number
GB1473318A
GB1473318A GB2523773A GB2523773A GB1473318A GB 1473318 A GB1473318 A GB 1473318A GB 2523773 A GB2523773 A GB 2523773A GB 2523773 A GB2523773 A GB 2523773A GB 1473318 A GB1473318 A GB 1473318A
Authority
GB
United Kingdom
Prior art keywords
concentration
therapeutically useful
ethyl cellulose
cellulose
carboxychromon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2523773A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB2523773A priority Critical patent/GB1473318A/en
Priority to US05/471,141 priority patent/US3975536A/en
Priority to FR7417407A priority patent/FR2230358A2/en
Priority to DE19742425281 priority patent/DE2425281A1/en
Priority to JP49058021A priority patent/JPS5756448B2/ja
Priority to US05/677,274 priority patent/US4053628A/en
Publication of GB1473318A publication Critical patent/GB1473318A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1473318 Pharmaceutical compositions FISONS Ltd 15 May 1974 [25 May 1973 (2) 12 July 1973] 25237/73 25238/73 and 33325/73 Addition to 1399834 Heading A5B Pharmaceutical compositions comprise a substantially clear sterile aqueous solution containing, as active ingredient, a therapeutically useful proportion of 1, 3-bis (2-carboxychromon-5-yloxy)-propan-2-ol, or a pharmaceutically acceptable salt thereof, and comprising an additional compound which is therapeutically useful in the eye, or an additive to increase the viscosity or to prolong the action of the active ingredient, or wherein the concentration of "metal ions" is less than 20 ppm, or wherein the concentration of Mg<++> is less than 0.2 ppm, or comprising dextrose or mannitol, or comprising sodium citrate/citric acid, or boric acid/sodium borate, or containing a concentration of chelating or sequestering agent in the range of from 0.005 to 0.1 % w/v. The additional therapeutically useful compounds include anti-histamines e.g. antazoline or diphenhydramine hydrochloride; anti-inflammatory agents e.g. prednisolone; antibacterials e.g. sulphacetamide and propamidine isethionate; antibiotics e.g. tetracycline, chloramphenicol, neomycin and fromycetin; antimycotics e.g. nystatin and amphotericin B; decongestants e.g. phenylephrine; anti-viral agents e.g. idoxuridine and vasoconstrictors e.g. oxymetazoline. The viscosity increasing additive may be methyl cellulose, hydroxypropylmethyl cellulose hydroxy propyl ethyl cellulose, hydroxy ethyl cellulose, ethyl hydroxy ethyl cellulose, a polyvinyl alcohol, gelatin, polyvinyl pyrrolidone, a polyethylene glycol, a propylene glycol and/or glycerin. The compositions may be used in the treatment of allergic conditions of the eyes and nose. Reference has been directed by the comptroller to Specification 1144905.
GB2523773A 1971-05-12 1973-05-25 Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof Expired GB1473318A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB2523773A GB1473318A (en) 1973-05-25 1973-05-25 Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US05/471,141 US3975536A (en) 1971-05-12 1974-05-17 Composition
FR7417407A FR2230358A2 (en) 1973-05-25 1974-05-20 Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE19742425281 DE2425281A1 (en) 1973-05-25 1974-05-24 PHARMACEUTICAL COMPOSITION
JP49058021A JPS5756448B2 (en) 1973-05-25 1974-05-24
US05/677,274 US4053628A (en) 1971-05-12 1976-04-15 Composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2523773A GB1473318A (en) 1973-05-25 1973-05-25 Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof

Publications (1)

Publication Number Publication Date
GB1473318A true GB1473318A (en) 1977-05-11

Family

ID=10224431

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2523773A Expired GB1473318A (en) 1971-05-12 1973-05-25 Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof

Country Status (1)

Country Link
GB (1) GB1473318A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2464716A1 (en) * 1979-09-07 1981-03-20 Upjohn Co COMPOSITION CONTAINING A DISODIUM CHROMOGLYCATE BIOLOGIST FOR THE PREVENTION OR TREATMENT OF MINERAL PATHOLOGICAL RESORPTION CONDITIONS IN LIVING PLANTS
GB2167300A (en) * 1984-11-23 1986-05-29 Fisons Plc Nasal/opthalmic sodium cromoglycate preparation
BE1005196A0 (en) * 1992-07-07 1993-05-18 Fisons Plc AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE.
GB2262448A (en) * 1992-07-07 1993-06-23 Fisons Plc Aqueous formulations of sodium cromoglycate

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2464716A1 (en) * 1979-09-07 1981-03-20 Upjohn Co COMPOSITION CONTAINING A DISODIUM CHROMOGLYCATE BIOLOGIST FOR THE PREVENTION OR TREATMENT OF MINERAL PATHOLOGICAL RESORPTION CONDITIONS IN LIVING PLANTS
GB2167300A (en) * 1984-11-23 1986-05-29 Fisons Plc Nasal/opthalmic sodium cromoglycate preparation
BE1005196A0 (en) * 1992-07-07 1993-05-18 Fisons Plc AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE.
GB2262448A (en) * 1992-07-07 1993-06-23 Fisons Plc Aqueous formulations of sodium cromoglycate
FR2686513A1 (en) * 1992-07-07 1993-07-30 Fisons Plc Aqueous pharmaceutical compositions of sodium cromoglycate
EP0587264A1 (en) * 1992-07-07 1994-03-16 FISONS plc Aqueous pharmaceutical formulations of sodium cromoglycate
GB2262448B (en) * 1992-07-07 1994-03-30 Fisons Plc Aqueous pharmaceutical formulations of sodium cromoglycate
US5475023A (en) * 1992-07-07 1995-12-12 Fisons Plc Aqueous pharmaceutical formulations of sodium cromoglycate

Similar Documents

Publication Publication Date Title
US6776982B2 (en) Autoclavable pharmaceutical compositions containing a chelating agent
US6576649B1 (en) Method for treating pharmaceutical compositions
ES2542728T3 (en) Pharmaceutical compositions that have desirable bioavailability
US4607038A (en) Ophthalmic pranoprofen compositions
US4201706A (en) Treatment of corneal edema
US4053628A (en) Composition
US20140088107A1 (en) Ophthalmic preparation comprising a pgf2alpha analogue
US6291519B1 (en) Method of preventing damage to eye tissue
US3975536A (en) Composition
US20120190653A1 (en) Therapeutic eye drop comprising doxycycline and a stabilizer
GB1473318A (en) Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
IE36337L (en) Pharmaceutical compositions
DE2425281A1 (en) PHARMACEUTICAL COMPOSITION
US10610509B2 (en) Combinations of prostaglandins and nitric oxide donors
ES2358558T3 (en) THIOPHENE DERIVATIVES AS MEDICINES FOR THE TREATMENT OF EYE HYPERTENSION.
JP2001131055A (en) Liquid agent, removal of white cloudiness of liquid agent and acceleration of trans-mucous membrane absorption of liquid agent
NO179472B (en) Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes
CA2529860A1 (en) Ophthalmic composition
KR100392481B1 (en) Dexamethasone gel
HUT63060A (en) Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists
EP0212927B1 (en) Pharmaceutical composition comprising sodium cromoglycate and a mucolytic agent
US5733938A (en) Combination of levobunolol and dipivefrin for topical ophthalmic use
TWI712429B (en) Water-based pharmaceutical composition
TR201603837A1 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
PS Patent sealed